Casirivimab-Imdevimab in high-risk patients with COVID-19: a single center "Real-life" experience

被引：0
|
作者：
Marc, Hildebrand [1 ]
Jean-Christophe, Goffard [1 ]
Bruno, Couturier [1 ]
Benoit, Vokaer [1 ]
Frederic, Vandergheynst [1 ]
机构：
[1] Erasme Univ Hosp, Brussels, Belgium
来源：
ACTA CLINICA BELGICA | 2021年 / 76卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
77
引用
收藏
页码：63 / 63
页数：1
相关论文
共 50 条
  • [1] Casirivimab-imdevimab for Treatment of COVID-19 in Solid Organ Transplant Recipients: An Early Experience
    Dhand, Abhay
    Lobo, Stephen A.
    Wolfe, Kevin
    Feola, Nicholas
    Lee, Leslie
    Nog, Rajat
    Chen, Donald
    Glicklich, Daniel
    Diflo, Thomas
    Nabors, Christopher
    TRANSPLANTATION, 2021, 105 (07) : E68 - E69
  • [2] Clinical efficacy of casirivimab-imdevimab antibody combination treatment in patients with COVID-19 Delta variant
    Miyashita, Naoyuki
    Nakamori, Yasushi
    Ogata, Makoto
    Fukuda, Naoki
    Yamura, Akihisa
    Ishiura, Yoshihisa
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2022, 28 (09) : 1344 - 1346
  • [3] WHO provides 2 conditional recommendations for casirivimab-imdevimab combination therapy in COVID-19
    Dunne, Cody
    Lang, Eddy
    ANNALS OF INTERNAL MEDICINE, 2022, 175 (01) : JC6 - JC6
  • [4] Impact of Antibody Cocktail Therapy Combined with Casirivimab and Imdevimab on Clinical Outcome for patients with COVID-19 in A Real-Life Setting: A Single Institute Analysis
    Kakinoki, Yasutaka
    Yamada, Kazuki
    Tanino, Yoko
    Suzuki, Keiko
    Ichikawa, Takaya
    Suzuki, Naoki
    Asari, Go
    Nakamura, Ai
    Kukita, Shin
    Uehara, Akito
    Saito, Seisuke
    Kuroda, Shohei
    Sakagami, Hidemitsu
    Nagashima, Yuuki
    Takahashi, Kae
    Suzuki, Satoshi
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2022, 117 : 189 - 194
  • [5] Casirivimab/imdevimab plus remdesivir in hospitalized patients with severe Covid-19: A single centre experience
    Moriello, Nicola Schiano
    Buonomo, Antonio Riccardo
    Scotto, Riccardo
    Pinchera, Biagio
    Sarno, Marina
    Fusco, Ludovica
    Viceconte, Giulio
    Iuliano, Antonio
    Zappulo, Emanuela
    Foggia, Maria
    Villari, Riccardo
    Gentile, Ivan
    HELIYON, 2023, 9 (02)
  • [6] Casirivimab and Imdevimab for the Treatment of Hospitalized Patients With COVID-19
    Somersan-Karakaya, Selin
    Mylonakis, Eleftherios
    Menon, Vidya P.
    Wells, Jason C.
    Ali, Shazia
    Sivapalasingam, Sumathi
    Sun, Yiping
    Bhore, Rafia
    Mei, Jingning
    Miller, Jutta
    Cupelli, Lisa
    Forleo-Neto, Eduardo
    Hooper, Andrea T.
    Hamilton, Jennifer D.
    Pan, Cynthia
    Pham, Viet
    Zhao, Yuming
    Hosain, Romana
    Mahmood, Adnan
    Davis, John D.
    Turner, Kenneth C.
    Kim, Yunji
    Cook, Amanda
    Kowal, Bari
    Soo, Yuhwen
    DiCioccio, A. Thomas
    Geba, Gregory P.
    Stahl, Neil
    Lipsich, Leah
    Braunstein, Ned
    Herman, Gary A.
    Yancopoulos, George D.
    Weinreich, David M.
    JOURNAL OF INFECTIOUS DISEASES, 2022, 227 (01): : 23 - 34
  • [7] Real-World Clinical Outcomes of Bamlanivimab and Casirivimab-Imdevimab Among High-Risk Patients With Mild to Moderate Coronavirus Disease 2019
    Ganesh, Ravindra
    Philpot, Lindsey M.
    Bierle, Dennis M.
    Anderson, Ryan J.
    Arndt, Lori L.
    Arndt, Richard F.
    Culbertson, Tracy L.
    Borgen, Molly J. Destro
    Hanson, Sara N.
    Kennedy, Brian D.
    Kottke, Brian B.
    Larsen, Jennifer J.
    Ramar, Priya
    Rosedahl, Jordan K.
    Seville, Maria Teresa
    Speicher, Leigh L.
    Tulledge-Scheitel, Sidna M.
    Wilker, Caroline G.
    Razonable, Raymund R.
    JOURNAL OF INFECTIOUS DISEASES, 2021, 224 (08): : 1278 - 1286
  • [8] Reverse Takotsubo Cardiomyopathy After Casirivimab-Imdevimab Therapy in a Patient with COVID-19: A Case Report
    Salehin, Salman
    Abu Jazar, Deaa
    Hasan, Syed Mustajab
    Al-Sudani, Hussein
    Raja, Muhammad W.
    AMERICAN JOURNAL OF CASE REPORTS, 2022, 23
  • [9] Use of Monoclonal Antibody Casirivimab-Imdevimab for Treatment of COVID-19 in Kidney Transplant Recipients.
    El Chediak, A.
    Bloch, K.
    Forbes, R.
    Langone, A.
    Concepcion, B. P.
    Sarrell, B. A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 1061 - 1061
  • [10] Casirivimab-Imdevimab treatment is associated with reduced rates of hospitalization among high-risk patients with mild to moderate coronavirus disease-19
    Razonable, Raymund R.
    Pawlowski, Colin
    O'Horo, John C.
    Arndt, Lori L.
    Arndt, Richard
    Bierle, Dennis M.
    Borgen, Molly Destro
    Hanson, Sara N.
    Hedin, Michelle C.
    Lenehan, Patrick
    Puranik, Arjun
    Seville, Maria T.
    Speicher, Leigh L.
    Tulledge-Scheitel, Sidna M.
    Venkatakrishnan, A. J.
    Wilker, Caroline G.
    Badley, Andrew D.
    Ganesh, Ravindra
    ECLINICALMEDICINE, 2021, 40
12345